|
1
|
Thun MJ, DeLancey JO, Center MM, Jemal A
and Ward EM: The global burden of cancer: priorities for
prevention. Carcinogenesis. 31:100–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Power DG, Kelsen DP and Shah MA: Advanced
gastric cancer–slow but steady progress. Cancer Treat Rev.
36:384–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rohatgi PR, Yao JC, Hess K, et al: Outcome
of gastric cancer patients after successful gastrectomy: influence
of the type of recurrence and histology on survival. Cancer.
107:2576–2580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ott K, Lordick F, Blank S and Büchler M:
Gastric cancer: surgery in 2011. Langenbecks Arch Surg.
396:743–758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tetzlaff ED, Cheng JD and Ajani JA: Review
of docetaxel in the treatment of gastric cancer. Ther Clin Risk
Manag. 4:999–1007. 2008.
|
|
6
|
Claas C, Stipp CS and Hemler ME:
Evaluation of prototype transmembrane 4 superfamily protein
complexes and their relation to lipid rafts. J Biol Chem.
276:7974–7984. 2001. View Article : Google Scholar
|
|
7
|
Maecker HT, Todd SC and Levy S: The
tetraspanin superfamily: molecular facilitators. FASEB J.
11:428–442. 1997.PubMed/NCBI
|
|
8
|
Todres E, Nardi JB and Robertson HM: The
tetraspanin superfamily in insects. Insect Mol Biol. 9:581–590.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fitter S, Sincock PM, Joliffe CN and
Ashman LK: Transmembrane 4 superfamily protein CD151 (PETA-3)
associates with beta1 and alpha IIb beta3 integrins in
haematopoietic cell lines and modulates cell-cell adhesion. Biochem
J. 338:61–70. 1999. View Article : Google Scholar
|
|
10
|
Horváth G, Serru V, Clay D, Billard M,
Boucheix C and Rubinstein E: CD19 is linked to the
integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem.
273:30537–30543. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Indig FE, Diaz-Gonzales F and Ginsberg MH:
Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa)
complex in platelet membranes and transfected cells. Biochem J.
327:291–298. 1997.PubMed/NCBI
|
|
12
|
Lozahic S, Christiansen D, Manié S,
Gerlier D, Billard M, Boucheix C and Rubinstein E: CD46 (membrane
cofactor protein) associates with multiple beta1 integrins and
tetraspans. Eur J Immunol. 30:900–907. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tiwari-Woodruff SK, Buznikov AG, Vu TQ,
Micevych PE, Chen K, Kornblum HI and Bronstein JM: OSP/claudin-11
forms a complex with a novel member of the tetraspanin super family
and beta1 integrin and regulates proliferation and migration of
oligodendrocytes. J Cell Biol. 153:295–305. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Claas C, Seiter S, Claas A, Savelyeva L,
Schwab M and Zöller M: Association between the rat homologue of
CO-029, a metastasis-associated tetraspanin molecule and
consumption coagulopathy. J Cell Biol. 141:267–280. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Odintsova E, Sugiura T and Berditchevski
F: Attenuation of EGF receptor signaling by a metastasis
suppressor, the tetraspanin CD82/KAI-1. Curr Biol. 10:1009–1012.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Testa JE, Brooks PC, Lin JM and Quigley
JP: Eukaryotic expression cloning with an antimetastatic monoclonal
antibody identifies a tetraspanin (PETA-3/CD151) as an effector of
human tumor cell migration and metastasis. Cancer Res.
59:3812–3820. 1999.PubMed/NCBI
|
|
17
|
Greco C, Bralet MP, Ailane N,
Dubart-Kupperschmitt A, Rubinstein E, Le Naour F and Boucheix C:
E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell
motility control in human colon carcinoma. Cancer Res.
170:7674–7683. 2010. View Article : Google Scholar
|
|
18
|
Zhou Z, Ran YL, Hu H, et al: TM4SF3
promotes esophageal carcinoma metastasis via upregulating ADAM12m
expression. Clin Exp Metastasis. 25:537–548. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herlevsen M, Schmidt DS, Miyazaki K and
Zöller M: The association of the tetraspanin D6.1A with the
alpha6beta4 integrin supports cell motility and liver metastasis
formation. J Cell Sci. 116:4373–4390. 2006. View Article : Google Scholar
|
|
20
|
Kanetaka K, Sakamoto M, Yamamoto Y,
Yamasaki S, Lanza F, Kanematsu T and Hirohashi S: Overexpression of
tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol.
35:637–642. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sartore-Bianchi A, Bencardino K, Di
Nicolantonio F, et al: Integrated molecular dissection of the
epidermal growth factor receptor (EFGR) oncogenic pathway to
predict response to EGFR-targeted monoclonal antibodies in
metastatic colorectal cancer. Target Oncol. 5:19–28. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lafky JM, Wilken JA, Baron AT and Maihle
NJ: Clinical implications of the ErbB/epidermal growth factor (EGF)
receptor family and its ligands in ovarian cancer. Biochim Biophys
Acta. 1785:232–265. 2008.PubMed/NCBI
|
|
23
|
Lin JX, Jia YD and Zhang CQ: Effect of
epidermal growth factor on follicle-stimulating hormone-induced
proliferation of granulosa cells from chicken prehierarchical
follicles. J Zhejiang Univ Sci B. 12:875–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsumura N, Zembutsu H, Yamaguchi K, et
al: Identification of novel molecular markers for detection of
gastric cancer cells in the peripheral blood circulation using
genome-wide microarray analysis. Exp Ther Med. 2:705–713.
2011.PubMed/NCBI
|
|
25
|
Ross JS and McKenna BJ: The HER-2/neu
oncogene in tumors of the gastrointestinal tract. Cancer Invest.
19:554–568. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Wilson EJ, Osburn J and Delvalle
J: Epidermal growth factor inhibits carbachol-stimulated canine
parietal cell function via protein kinase C. Gastroenterology.
110:469–477. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma L, Liu ES, Chow JY, Wang JY and Cho CH:
Interactions of EGF and ornithine decarboxylase activity in the
regulation of gastric mucus synthesis in cigarette smoke exposed
rats. Chin J Physiol. 42:137–143. 1999.
|
|
28
|
Yasui W, Hata J, Yokozaki H, Nakatani H,
Ochiai A, Ito H and Tahara E: Interaction between epidermal growth
factor and its receptor in progression of human gastric carcinoma.
Int J Cancer. 41:211–217. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jonjić N1, Kovac K, Krasević M, Valković
T, Ernjak N, Sasso F and Melato M: Epidermal growth factor-receptor
expression correlates with tumour cell proliferation and prognosis
in gastric cancer. Anticancer Res. 17:3883–3888. 1997.
|
